Believe it or not, there are other things going on at The Ohio State University besides football and basketball. In our new feature, Campus Spotlight, we will periodically catch you up with what is happening with those sports and activities.
On these blogs the topics are likely about football and men's basketball. I'd like to cover another topic. The other nationally ranked team at OSU is at the Ohio State University Medical Center. Specifically, those at the the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
This is the first of two parts covering "The James". We had a few questions about The James and they were more than answered by Eileen Scahill, Media Relations Manager, Ohio State University Medical Center. Please join me for Part 1.
Can you please start out with an overview of The James' mission? That might lead to the following questions...
Our Vision - Creating a cancer-free world. One person, one discovery at a time.
Our Mission - To eradicate cancer from individuals’ lives by creating knowledge and integrating groundbreaking research with excellence in education and patient-centered care
Overview - The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC–James) is one of the nation's premier cancer centers for the prevention, detection and treatment of cancer. It is the Midwest's first and Ohio's only fully dedicated cancer hospital and research institute.The OSUCCC–James is one of only 40 centers in the United States designated by the National Cancer Institute a Comprehensive Cancer Center. In addition, we are a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers.In 2009, The Ohio State University Board of Trustees approved a $1 billion expansion of the cancer hospital and Medical Center facilities, including a new 276-bed (not including ICU) cancer hospital and critical care building. This increased capacity to help keep pace with the projected 21 percent growth in admissions during the next decade.
The new James Cancer Hospital and Solove Research Institute's state-of-the-art facilities will allow the Medical Center to serve 310,000 patients annually.
OSU Comprehensive Cancer Center
Established in 1973 as a cancer center and receiving the NCI Comprehensive Cancer Center designation in 1976, the OSUCCC–James has six highly interactive cancer research programs that include more than 200 leading cancer researchers and scientists from 12 of the 18 colleges at Ohio State and includes physicians from 16 specialties.
The National Cancer Institute (NCI) has awarded The Ohio State University Comprehensive Cancer Center the highest possible rating – “exceptional” – after completing its scientific peer review of the University’s cancer program. This action renews the Ohio State University’s designation as an NCI Comprehensive Cancer Center for at least another five years. The panel deemed Ohio State’s Comprehensive Cancer Center as “the model for other matrix university-based centers.”
During the past 15 years, the OSUCCC – James has recruited some of the world’s leading cancer researchers and seen extraordinary growth in its science-based clinical programs. Because of that, Ohio State's National Cancer Institute (NCI) funding has more than quadrupled, making this University the 15th highest NCI-funded cancer program in the nation.
Ohio States' Comprehensive Cancer Center–James Cancer Hospital and Solove Research Institute
Ranked as one of the top cancer hospitals in the nation, the OSUCCC–James is the Midwest’s first and Ohio’s only freestanding cancer hospital.
Our ability to translate groundbreaking cancer research into innovative patient care distinguishes The James as an academic medical institution and positions us for a leadership role in personalized medicine.
The innovation creates a multidisciplinary approach to cancer care with surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, researchers and more, all collaborating to provide the latest in cancer diagnosis, treatment and prevention.
The hospital also includes a 24-bed bone marrow transplant unit, intra-operative radiation therapy, special isolation rooms, chemotherapy and special transfusion areas and specialized diagnostic equipment. It also has a 9-bed clinical trials unit for early phase investigational drug delivery. The OSUCCC–James is one of only seven centers in the country approved by the National Cancer Institute to conduct both phase I and phase II clinical trials for new anti-cancer drugs.
Ohio State’s cancer program is also part of the Lance Armstrong Foundation’s LIVESTRONG™ Survivorship Center of Excellence Network, one of only eight such centers in the nation.
With "The James" affiliated with Ohio State University, I'm assuming that a significant amount of research takes place there. What specific areas of research do you focus on and what specific types of cancer has research focus? How are research results shared with other cancer treatment centers, such as Roswell Park Cancer Institute, for example?
The James is one of only seven centers in the country funded by the National Cancer Institute to conduct both phase I and phase II clinical trials for new anti-cancer drugs. The resulting benefit to patients is that they have access to some of the most advanced cancer treatments and clinical trials offered anywhere in the world.
In cancer research, every discovery is significant for its potential use against a dreaded disease. Hence the rising global emphasis on “translational research,” which the NCI defines as “transforming scientific discoveries from laboratory, clinical and population studies into medical applications for reducing cancer incidence, morbidity or mortality”.
The OSUCCC-James provides an ideal atmosphere for translational research. Research collaboration is evident from our standing as one of the most comprehensive health sciences institutions in the United States, to our emphasis on open labs and shared resources that promote working across disciplines and efficient use of research funding, to our creation of biomedical informatics data banks that help us share our discoveries across the University and around the world.
OSUCCC-James researchers are conducting hundreds of clinical trials in virtually every form of cancer, with particular focus on hematologic malignancies, including leukemias, lymphomas and multiple myeloma; along with solid tumor including breast, lung, and prostate cancers. Other clinical trials are being conducted for colorectal cancer, ovarian cancer, uterine cancer; liver cancer, melanoma, stomach and thyroid cancers, among others.
From how far away do patients come for treatment? How large is your treatment center? What portion of the James' efforts are spent on research?
We attract patients primarily from central Ohio, but also have patients who seek treatment here from elsewhere in Ohio and nationwide.
For Fiscal Year 2011, we had: 10,368 Hospital Admissions, 239,155 Outpatient Visits and 107,452 Clinic Visits
Our research portfolio is in excess of $110 million, representing roughly one-fifth of Ohio State’s entire research portfolio.
What patient support programs do you have at The James?
Currently we have 15 disease-specific support groups and in each of the support groups we offer caregiver support as well as support to the cancer survivor. We also put on an annual caregiver conference in conjunction with the neuro-oncology team.
Last question: for the Buckeye blog community, bloggers, writers, readers; what can we do to support The James in it's mission?
Despite the fact that the groundbreaking cancer research performed at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC-James) is beating cancer every day, there remains a desperate need for additional resources to fund the research that will change lives.
Moreover, due to ever-dwindling federal funding, it is becoming harder for great hospitals like OSUCCC-James to attract the talented doctors and scientists whose research will make the difference. Facing these obstacles in 2008, Dr. Michael Caligiuri, Director of the OSUCCC and CEO of The James, began exploring ways to fill the voids. Fortunately, Dr. Caligiuri quickly found gracious and enthusiastic support throughout the Columbus community. With the community’s support of Dr. Caligiuri's passion, Pelotonia was born, and through that support, 100% of every dollar raised by Pelotonia and its riders will directly support essential and innovative cancer research at the OSUCCC-James. By supporting the OSUCCC-James, Pelotonia is leading the charge against cancer - a charge that only becomes stronger with your help. During the first three years, Pelotonia has raised more than $25 million for cancer research at OSUCCC-James. For more information about Pelotonia, visit www.pelotonia.org
Speaking of Dr. Caligiuri, please click on the link, below, for a good, brief (<2min) presentation. And, of course, living in Buffalo, I would be remiss not to point out that Dr. Caligiuri is one of Buffalo's better “exports” to the world. You're welcome.
For more information about OSUCCC-James, please go to http://cancer.osu.edu/Pages/index.aspxThe